Mild Cognitive Impairment Clinical Trial
Official title:
Closed-Loop Brain Stimulation as a Potential Intervention for Cognitive Decline
The goal of this clinical study is to investigate the effectiveness of non-invasive stimulation to enhance cognitive control abilities in cognitively healthy adults and older adults diagnosed with mild cognitive disorder (MCI). The main questions it aims to answer are: - whether it is possible to restore various cognitive functions in older adults diagnosed with MCI by delivering theta burst stimulation (TBS), a form of transcranial magnetic stimulation, and - whether closed-loop TBS is able to induce therapeutic benefits that outperform open-loop TBS. Participants play a cognitive video game while a brain-computer interface (BCI) analyzes their electroencephalogram (EEG) signals and decodes the presence or absence of the contingent negative variation (CNV) potential, a marker of cognitive control. The BCI triggers TBS when its outputs indicate that the participant is not engaged properly in the video game. Researchers will compare the effects of sham, closed-loop, and open-loop TBS using the outcome metrics described below to see how much cognitive restorations is achievable with each stimulation modality.
Status | Recruiting |
Enrollment | 180 |
Est. completion date | December 31, 2026 |
Est. primary completion date | December 31, 2026 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 90 Years |
Eligibility | Inclusion Criteria: - Cognitively normal younger adults 1. Ages between 18 to 35 years 2. Good general health 3. Normal or corrected vision 4. Completed elementary school education or able to understand middle school level experiment instructions - Cognitively normal older adults 1. Ages between 60 to 90 years 2. Good general health 3. Normal or corrected vision 4. Completed elementary school education or able to understand middle school level experiment instructions 5. Score of 23 or higher on the Montreal Cognitive Assessment, a brief formal cognitive screening test, which is used to indicate absence of cognitive impairment - Older adults with mild cognitive impairment (MCI) 1. Ages between 60 to 90 years 2. Diagnosis of MCI according to the National Institute on Aging - Alzheimer's Association (NIA-AA) criteria 3. Good general health 4. Normal or corrected vision 5. Completed elementary school education or able to understand middle school level experiment instructions Exclusion Criteria: 1. Neurological or psychiatric diseases (e.g., personal history of epilepsy/seizure brain damage, multiple sclerosis, schizophrenia, substance use disorder, etc.). 2. Current use of psychotropic medications with cognitive side effects (e.g., benzodiazepines, anticonvulsants, antipsychotics, etc.) 3. Current use of cognitive enhancing medications (e.g., Adderall, Memantine, etc.) 4. Factors hindering EEG acquisition and TMS delivery (e.g., skin infection, wounds, dermatitis, etc.) 5. Factors hindering MRI acquisition (e.g., implants, metallic tattoos, etc.) |
Country | Name | City | State |
---|---|---|---|
United States | Health Discovery Building | Austin | Texas |
Lead Sponsor | Collaborator |
---|---|
University of Texas at Austin |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Behavioral performance of the video game task | The behavioral performance, pressing or not pressing a button, reflects the level of cognitive control performance of the subjects. It measures whether the participants made a correct decision, and their response time, in a given trial. | Up to 1 hour after intervention | |
Primary | Accuracy of the BCI classifier output | The BCI classifier output reflects the presence or absence of the cognitive EEG patterns elicited during the cognitive videogame tasks. For each participant, the BCI outputs will be compared to their behavioral responses (pressing or not pressing a button). | Up to 1 hour after intervention | |
Primary | Cognitive assessment I: Montreal Cognitive Assessment | Telephone version, Score range: 0 - 22* (Units on a Scale)
(* high scores = better) |
Up to 8 weeks after intervention | |
Primary | Cognitive assessment II: Hopkins Adult Reading Test | Score range: 70 - 131* (Units on a Scale)
(* high scores = better) |
Up to 8 weeks after intervention | |
Primary | Cognitive assessment III: Multilingual Naming Test | Score range: 0 - 32* (Units on a Scale)
(* high scores = better) |
Up to 8 weeks after intervention | |
Primary | Cognitive assessment IV: Animal Naming | Score range: 0 - 40* (Units on a Scale)
(* high scores = better) |
Up to 8 weeks after intervention | |
Primary | Cognitive assessment V: Number Span | Forward, Score range: 0 - 14* (Units on a Scale)
Backward, Score range: 0 - 14* (Units on a Scale) (* high scores = better) |
Up to 8 weeks after intervention | |
Primary | Cognitive assessment VI: Trail Making Test | Parts A and B, Score range: 10 - 300** (Units on a Scale)
(** high scores = worse) |
Up to 8 weeks after intervention | |
Primary | Cognitive assessment VII: Southwestern Assessment of Processing Speed | Score range: 0 - 75* (Units on a Scale)
(* high scores = better) |
Up to 8 weeks after intervention | |
Primary | Cognitive assessment VIII: Hopkins Verbal Learning Test-Revised | Immediate Total, Score range: 0 - 36* (Units on a Scale)
Delayed Recall, Score range:0 - 12* (Units on a Scale) Percent Retention, Score range:0 - 100* (Units on a Scale) (* high scores = better) |
Up to 8 weeks after intervention | |
Primary | Cognitive assessment IX: Brief Visuospatial Memory Test-Revised | Immediate Total, Score range: 0 - 36* (Units on a Scale)
Delayed Recall, Score range:0 - 12* (Units on a Scale) Percent Retention, Score range:0 - 100* (Units on a Scale) (* high scores = better) |
Up to 8 weeks after intervention | |
Primary | Cognitive assessment X: Controlled Oral Word Association Test | Score range: 0 - 80* (Units on a Scale)
(* high scores = better) |
Up to 8 weeks after intervention | |
Primary | Cognitive assessment XI: Stroop Color and Word Test | Word, Score range: 0 - 140* (Units on a Scale)
Color, Score range:0 - 120* (Units on a Scale) Color-Word, Score range:0 - 80* (Units on a Scale) (* high scores = better) |
Up to 8 weeks after intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04513106 -
Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial
|
N/A | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Active, not recruiting |
NCT03167840 -
Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment
|
N/A | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Not yet recruiting |
NCT05041790 -
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
|
Phase 4 | |
Recruiting |
NCT04121156 -
High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Completed |
NCT02774083 -
Cognitive Training Using Feuerstein Instrumental Enrichment
|
N/A | |
Completed |
NCT01315639 -
New Biomarker for Alzheimer's Disease Diagnostic
|
N/A | |
Enrolling by invitation |
NCT06023446 -
Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
|
||
Completed |
NCT04567745 -
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers
|
Phase 1 | |
Recruiting |
NCT05579236 -
Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
|
||
Completed |
NCT03583879 -
Using Gait Robotics to Improve Symptoms of Parkinson's Disease
|
N/A | |
Terminated |
NCT02503501 -
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
|
Phase 2 | |
Not yet recruiting |
NCT03740178 -
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
|
Phase 1 | |
Active, not recruiting |
NCT05204940 -
Longitudinal Observational Biomarker Study
|
||
Recruiting |
NCT02663531 -
Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Recruiting |
NCT03507192 -
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.
|
N/A |